Case Study: Top 5 Global Pharma Company achieves enhanced patient safety and daily remote lung monitoring with Medable

Optimizing choice, flexibility and outcomes with Patient-First Data Collection for Oncology

Top 5 Global Pharma Company, with a strong Oncology focus, needed a way to improve clinician oversight of patients between site visits to detect early signs of pulmonary toxicity and prompt interventions. They partnered with Medable to move beyond infrequent in‑clinic checks and deployed a decentralized clinical trial approach using Medable’s eCOA and sensor integration to capture daily lung function measures and patient‑reported symptoms remotely.

Medable implemented connected pulse oximeters (BYOD or provisioned), a mobile app workflow for daily SpO2 readings and symptom diaries, and real‑time data review by remote safety monitors across sites in 24 countries. The change produced a 7X increase in measurement frequency during dose escalation and up to 90X during follow‑up versus traditional schedules, with positive site and patient feedback, enhanced patient oversight and safety, reduced travel burden, and an expected 10–20% of patients receiving timelier interventions; studies began going live in Q4 2020.